In summary, targeting the excessive activation of the NLRP3 inflammasome provides a potential strategy for the prevention or treatment of inflammatory-related diseases such as sepsis, and in-depth analysis of the ubiquitination modification mechanism will lay the foundation for the development of new therapeutic targets [57,60,61,62]. Here, NLRP3 is linked to Sepsis.